Development of a value assessment framework for Health Technology Assessment in rare diseases drugs: insights from a Delphi study in Brazil (2025)
- Authors:
- Autor USP: AGUIAR, PATRICIA MELO - FCF
- Unidade: FCF
- DOI: 10.1017/S0266462324004835
- Subjects: DOENÇAS RARAS; MEDICAMENTO; AVALIAÇÃO DE TECNOLOGIAS DA SAÚDE; SISTEMA ÚNICO DE SAÚDE
- Language: Inglês
- Imprenta:
- Source:
- Título: International Journal of Technology Assessment in Health Care
- ISSN: 0266-4623
- Volume/Número/Paginação/Ano: v. 41, n. 1, p. 1-12, 2025
- Status:
- Artigo aberto em periódico híbrido (Hybrid Open Access)
- Versão do Documento:
- Versão publicada (Published version)
- Acessar versão aberta:
-
ABNT
BIGLIA, Luiza Vasconcelos et al. Development of a value assessment framework for Health Technology Assessment in rare diseases drugs: insights from a Delphi study in Brazil. International Journal of Technology Assessment in Health Care, v. 41, n. 1, p. 1-12, 2025Tradução . . Disponível em: https://dx.doi.org/10.1017/S0266462324004835. Acesso em: 06 maio 2026. -
APA
Biglia, L. V., Felippini, A., Ribeiro, T. B., Lima, T. de M., & Aguiar, P. M. (2025). Development of a value assessment framework for Health Technology Assessment in rare diseases drugs: insights from a Delphi study in Brazil. International Journal of Technology Assessment in Health Care, 41( 1), 1-12. doi:10.1017/S0266462324004835 -
NLM
Biglia LV, Felippini A, Ribeiro TB, Lima T de M, Aguiar PM. Development of a value assessment framework for Health Technology Assessment in rare diseases drugs: insights from a Delphi study in Brazil [Internet]. International Journal of Technology Assessment in Health Care. 2025 ; 41( 1): 1-12.[citado 2026 maio 06 ] Available from: https://dx.doi.org/10.1017/S0266462324004835 -
Vancouver
Biglia LV, Felippini A, Ribeiro TB, Lima T de M, Aguiar PM. Development of a value assessment framework for Health Technology Assessment in rare diseases drugs: insights from a Delphi study in Brazil [Internet]. International Journal of Technology Assessment in Health Care. 2025 ; 41( 1): 1-12.[citado 2026 maio 06 ] Available from: https://dx.doi.org/10.1017/S0266462324004835 - Economic evaluations on the use of aripiprazole for patients with schizophrenia: a systematic review
- Prevalence of depression and anxiety among pharmacy students: a systematic review
- Does sex affect the efficacy, safety, and quality of life outcomes for patients using angiotensin receptor neprilysin inhibitor, soluble guanylate cyclase stimulators, and cardiac myosin activators in heart failure? a systematic review
- Pharmacist interventions in schizophrenia and bipolar affective disorder: a systematic review and meta-analysis
- Use of medications by patients who are Deaf or Hard of Hearing: Reflections for the promotion of rational use
- Colaboração médico-farmacêutico no manejo de pacientes com diabetes mellitus tipo 2: expectativas e resultados
- Pharmacist participated medication review in different practice settings: service or intervention? an overview of systematic reviews
- Estomatite aftosa recorrente (afta)
- Hiperplasia prostática benigna
- Evaluation of mobile applications focused on the care of patients with anxiety disorders: a systematic review in app stores in Brazil
Informações sobre a disponibilidade de versões do artigo em acesso aberto coletadas automaticamente via oaDOI API (Unpaywall).
Por se tratar de integração com serviço externo, podem existir diferentes versões do trabalho (como preprints ou postprints), que podem diferir da versão publicada.
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
